J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Man, F. H.
Right arrow Articles by Havekes, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Man, F. H.
Right arrow Articles by Havekes, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 38, 2465-2472, Copyright © 1997 by Lipid Research, Inc.


ARTICLES

Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase

FH de Man, F de Beer, A van der Laarse, AH Smelt and LM Havekes
Department of Cardiology, Leiden University Medical Centre, The Netherlands.

An in vitro assay to study lipolysis of very low density lipoproteins (VLDL) by heparan sulfate proteoglycan (HSPG-bound lipoprotein lipase (LPL) was developed. Optimal conditions for VLDL lipolysis by HSPG- bound LPL were obtained by incubating plastic wells with 0.5 microg HSPG and 1.5 microg LPL, subsequently. Control experiments with heparinase indicate that at least 90% of the LPL activity is derived from LPL bound to heparan sulfate chains. For HSPG-LPL-mediated lipolysis, the apparent Km and Vmax values were 0.36 +/- 0.11 mM VLDL- triglycerides and 1.2 +/- 0.1 microM free fatty acids/min x ng LPL, respectively. The mean intra-assay and inter-assay coefficients of variance were 5% and 8%, respectively.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Grosskopf, N. Baroukh, S.-J. Lee, Y. Kamari, D. Harats, E. M. Rubin, L. A. Pennacchio, and A. D. Cooper
Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2573 - 2579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Merkel, B. Loeffler, M. Kluger, N. Fabig, G. Geppert, L. A. Pennacchio, A. Laatsch, and J. Heeren
Apolipoprotein AV Accelerates Plasma Hydrolysis of Triglyceriderich Lipoproteins by Interaction with Proteoglycan-bound Lipoprotein Lipase
J. Biol. Chem., June 3, 2005; 280(22): 21553 - 21560.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Conde-Knape, A. Bensadoun, J. H. Sobel, J. S. Cohn, and N. S. Shachter
Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase
J. Lipid Res., December 1, 2002; 43(12): 2136 - 2145.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. de Beer, K. W. van Dijk, M. C. Jong, L. C. van Vark, A. van der Zee, M. H. Hofker, F. J. Fallaux, R. C. Hoeben, A. H. M. Smelt, and L. M. Havekes
Apolipoprotein E2 (Lys146->Gln) Causes Hypertriglyceridemia due to an Apolipoprotein E Variant-Specific Inhibition of Lipolysis of Very Low Density Lipoproteins-Triglycerides
Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1800 - 1806.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Sambandam, M. A. Abrahani, S. Craig, O. Al-Atar, E. Jeon, and B. Rodrigues
Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1874 - H1882.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. C. Jong, W. L. Hendriks, L. C. van Vark, V. E. H. Dahlmans, J. E. M. Groener, and L. M. Havekes
Oxidized VLDL Induces Less Triglyceride Accumulation in J774 Macrophages Than Native VLDL Due to an Impaired Extracellular Lipolysis
Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 144 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. M. van Vlijmen, A. Rohlmann, S. T. Page, A. Bensadoun, I. S. T. Bos, T. J. C. van Berkel, L. M. Havekes, and J. Herz
An Extrahepatic Receptor-associated Protein-sensitive Mechanism Is Involved in the Metabolism of Triglyceride-rich Lipoproteins
J. Biol. Chem., December 3, 1999; 274(49): 35219 - 35226.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. de Beer, W. L. Hendriks, L. C. van Vark, S. W.A. Kamerling, K. W. van Dijk, M. H. Hofker, A. H.M. Smelt, and L. M. Havekes
Binding of ß-VLDL to Heparan Sulfate Proteoglycans Requires Lipoprotein Lipase, Whereas ApoE Only Modulates Binding Affinity
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 633 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Ramsamy, T. A.-M. Neville, B. M. Chauhan, D. Aggarwal, and D. L. Sparks
Apolipoprotein A-I Regulates Lipid Hydrolysis by Hepatic Lipase
J. Biol. Chem., October 20, 2000; 275(43): 33480 - 33486.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.